Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SFOSF · OTC
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$12,959$13,716$13,524$13,508
Short-Term Investments$2,680$2,354$2,596$2,122
Receivables$9,959$9,350$9,430$9,820
Inventory$6,744$6,823$7,259$7,435
Other Curr. Assets$2,001$2,195$1,682$1,642
Total Curr. Assets$34,342$34,439$34,491$34,527
Property Plant & Equip (Net)$23,983$23,657$23,411$21,861
Goodwill$10,926$10,888$10,905$10,801
Intangibles$19,565$19,405$19,336$17,928
Long-Term Investments$0$23,882$23,269$25,978
Tax Assets$748$754$758$791
Other NC Assets$29,264$4,967$5,291$3,378
Total NC Assets$84,486$83,552$82,970$80,737
Other Assets$0$0$0$0
Total Assets$118,828$117,990$117,461$115,265
Liabilities
Payables$5,450$5,439$5,997$5,526
Short-Term Debt$17,862$17,874$18,711$18,680
Tax Payable$467$649$561$537
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,245$11,538$12,183$12,775
Total Curr. Liab.$36,023$35,501$37,453$37,518
LT Debt$14,349$14,190$12,985$11,087
Deferred Rev, NC$675$650$658$605
Deferred Tax Liab, NC$3,389$3,445$3,245$3,465
Other NC Liab.$4,076$3,355$3,186$3,395
Total NC Liab.$22,489$21,640$20,074$18,553
Other Liabilities$0$0$0$0
Cap. Leases$2,754$2,629$2,542$2,217
Total Liabilities$58,513$57,141$57,527$56,070
Equity
Pref Stock$0$0$0$0
Common Stock$2,670$2,671$2,671$2,671
Retained Earnings$27,413$27,318$26,553$25,828
AOCI$0$0$0$19,009
Other Equity$17,315$17,934$18,037-$207
Total Equity$47,398$47,924$47,261$47,301
Supplemental Information
Minority Interest$12,917$12,926$12,673$11,893
Total Liab. & Tot. Equity$118,828$117,990$117,461$115,265
Net Debt$19,252$18,348$18,173$16,259
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Financial Statements & Key Stats | AlphaPilot